Loading…
Immune checkpoint blockade for glioma
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with diffuse glioma.
Saved in:
Published in: | Cochrane database of systematic reviews 2017-01, Vol.2017 (1) |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 1 |
container_start_page | |
container_title | Cochrane database of systematic reviews |
container_volume | 2017 |
creator | de Melo, Suely M Moraes, Fabio Ynoe Porfírio, Gustavo JM Elias Nunes da Silva, Mauricio EN De Cicco, Kelly Torloni, Maria Regina Riera, Rachel |
description | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with diffuse glioma. |
doi_str_mv | 10.1002/14651858.CD012532 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6464918</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_6464918</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2102-5e1d0973203e11e2798c8cc92c186ce962bd3b6b825988c56d7bdd04d0640e923</originalsourceid><addsrcrecordid>eNpVjMtKw0AUQAdBsFY_wF02LlPvnVdmNoLUV6HgRsFdmLlz28YmmZC0gn-voBtXB86BI8QVwgIB5A1qa9AZt1jeA0qj5ImY_Thfaq_ez8T5NH0AKI_oZuJ61XXHngvaMe2H3PSHIraZ9iFxscljsW2b3IULcboJ7cSXf5yLt8eH1-VzuX55Wi3v1iVJBFkaxgS-UhIUI7KsvCNH5CWhs8TeyphUtNFJ450jY1MVUwKdwGpgL9Vc3P5-h2PsOBH3hzG09TA2XRi_6hya-n_pm129zZ-11VZ7dOobxjNKYA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immune checkpoint blockade for glioma</title><source>Alma/SFX Local Collection</source><creator>de Melo, Suely M ; Moraes, Fabio Ynoe ; Porfírio, Gustavo JM ; Elias Nunes da Silva, Mauricio EN ; De Cicco, Kelly ; Torloni, Maria Regina ; Riera, Rachel</creator><creatorcontrib>de Melo, Suely M ; Moraes, Fabio Ynoe ; Porfírio, Gustavo JM ; Elias Nunes da Silva, Mauricio EN ; De Cicco, Kelly ; Torloni, Maria Regina ; Riera, Rachel</creatorcontrib><description>This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with diffuse glioma.</description><identifier>EISSN: 1469-493X</identifier><identifier>DOI: 10.1002/14651858.CD012532</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Medicine General & Introductory Medical Sciences</subject><ispartof>Cochrane database of systematic reviews, 2017-01, Vol.2017 (1)</ispartof><rights>Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. 2019 The Cochrane Collaboration</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail></links><search><creatorcontrib>de Melo, Suely M</creatorcontrib><creatorcontrib>Moraes, Fabio Ynoe</creatorcontrib><creatorcontrib>Porfírio, Gustavo JM</creatorcontrib><creatorcontrib>Elias Nunes da Silva, Mauricio EN</creatorcontrib><creatorcontrib>De Cicco, Kelly</creatorcontrib><creatorcontrib>Torloni, Maria Regina</creatorcontrib><creatorcontrib>Riera, Rachel</creatorcontrib><title>Immune checkpoint blockade for glioma</title><title>Cochrane database of systematic reviews</title><description>This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with diffuse glioma.</description><subject>Medicine General & Introductory Medical Sciences</subject><issn>1469-493X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVjMtKw0AUQAdBsFY_wF02LlPvnVdmNoLUV6HgRsFdmLlz28YmmZC0gn-voBtXB86BI8QVwgIB5A1qa9AZt1jeA0qj5ImY_Thfaq_ez8T5NH0AKI_oZuJ61XXHngvaMe2H3PSHIraZ9iFxscljsW2b3IULcboJ7cSXf5yLt8eH1-VzuX55Wi3v1iVJBFkaxgS-UhIUI7KsvCNH5CWhs8TeyphUtNFJ450jY1MVUwKdwGpgL9Vc3P5-h2PsOBH3hzG09TA2XRi_6hya-n_pm129zZ-11VZ7dOobxjNKYA</recordid><startdate>20170126</startdate><enddate>20170126</enddate><creator>de Melo, Suely M</creator><creator>Moraes, Fabio Ynoe</creator><creator>Porfírio, Gustavo JM</creator><creator>Elias Nunes da Silva, Mauricio EN</creator><creator>De Cicco, Kelly</creator><creator>Torloni, Maria Regina</creator><creator>Riera, Rachel</creator><general>John Wiley & Sons, Ltd</general><scope>5PM</scope></search><sort><creationdate>20170126</creationdate><title>Immune checkpoint blockade for glioma</title><author>de Melo, Suely M ; Moraes, Fabio Ynoe ; Porfírio, Gustavo JM ; Elias Nunes da Silva, Mauricio EN ; De Cicco, Kelly ; Torloni, Maria Regina ; Riera, Rachel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2102-5e1d0973203e11e2798c8cc92c186ce962bd3b6b825988c56d7bdd04d0640e923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Medicine General & Introductory Medical Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Melo, Suely M</creatorcontrib><creatorcontrib>Moraes, Fabio Ynoe</creatorcontrib><creatorcontrib>Porfírio, Gustavo JM</creatorcontrib><creatorcontrib>Elias Nunes da Silva, Mauricio EN</creatorcontrib><creatorcontrib>De Cicco, Kelly</creatorcontrib><creatorcontrib>Torloni, Maria Regina</creatorcontrib><creatorcontrib>Riera, Rachel</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cochrane database of systematic reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Melo, Suely M</au><au>Moraes, Fabio Ynoe</au><au>Porfírio, Gustavo JM</au><au>Elias Nunes da Silva, Mauricio EN</au><au>De Cicco, Kelly</au><au>Torloni, Maria Regina</au><au>Riera, Rachel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune checkpoint blockade for glioma</atitle><jtitle>Cochrane database of systematic reviews</jtitle><date>2017-01-26</date><risdate>2017</risdate><volume>2017</volume><issue>1</issue><eissn>1469-493X</eissn><abstract>This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness and safety of anti‐PD‐1 and anti‐PD‐L1 antibodies in the treatment of adults with diffuse glioma.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><doi>10.1002/14651858.CD012532</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1469-493X |
ispartof | Cochrane database of systematic reviews, 2017-01, Vol.2017 (1) |
issn | 1469-493X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6464918 |
source | Alma/SFX Local Collection |
subjects | Medicine General & Introductory Medical Sciences |
title | Immune checkpoint blockade for glioma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-06T15%3A26%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20checkpoint%20blockade%20for%20glioma&rft.jtitle=Cochrane%20database%20of%20systematic%20reviews&rft.au=de%20Melo,%20Suely%20M&rft.date=2017-01-26&rft.volume=2017&rft.issue=1&rft.eissn=1469-493X&rft_id=info:doi/10.1002/14651858.CD012532&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_6464918%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2102-5e1d0973203e11e2798c8cc92c186ce962bd3b6b825988c56d7bdd04d0640e923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |